Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Mechanism of extracellular release of human neutrophil calprotectin complex.

Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK.

J Leukoc Biol. 2001 Jul;70(1):130-4.

PMID:
11435495
3.

The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis.

Zadeh HH, Nichols FC, Miyasaki KT.

Periodontol 2000. 1999 Jun;20:239-88. Review. No abstract available.

PMID:
10522228
4.

Calprotectin and lactoferrin levels in the gingival crevicular fluid of children.

Miyasaki KT, Voganatsi A, Huynh T, Marcus M, Underwood S.

J Periodontol. 1998 Aug;69(8):879-83.

PMID:
9736370
5.

Beta-sheet antibiotic peptides as potential dental therapeutics.

Miyasaki KT, Lehrer RI.

Int J Antimicrob Agents. 1998 Feb;9(4):269-80. Review.

PMID:
9573496
6.

Killing of Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia by protegrins.

Miyasaki KT, Iofel R, Oren A, Huynh T, Lehrer RI.

J Periodontal Res. 1998 Feb;33(2):91-8.

PMID:
9553868
8.

Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria.

Miyasaki KT, Nemirovskiy E.

Oral Microbiol Immunol. 1997 Feb;12(1):27-32.

PMID:
9151641
9.

Identification of CG-1, a natural peptide antibiotic derived from human neutrophil cathepsin G.

Miyasaki KT, Qu XD, Harwig SS, Cho Y, Lehrer RI.

Adv Dent Res. 1995 Feb;9(1):63-6.

PMID:
7669217
10.

Neutrophil lysosomal nonoxidative microbicidal proteins in early-onset periodontitis.

Flemmig TF, Miyasaki KT.

Oral Microbiol Immunol. 1994 Oct;9(5):272-7.

PMID:
7808768
11.

The in vitro effect of human polymorphonuclear leukocyte azurophil granule components on natural killer cell cytotoxicity.

Lindemann RA, Lala A, Miyasaki KT.

Oral Microbiol Immunol. 1994 Jun;9(3):186-92.

PMID:
7936726
12.

In vitro candidastatic properties of the human neutrophil calprotectin complex.

Murthy AR, Lehrer RI, Harwig SS, Miyasaki KT.

J Immunol. 1993 Dec 1;151(11):6291-301.

PMID:
8245468
14.

Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases.

Eversole LR, Miyasaki KT, Christensen RE.

J Oral Pathol Med. 1993 Aug;22(7):303-7.

PMID:
8229866
15.
16.

The distribution of the antimicrobial protein, calprotectin, in normal oral keratinocytes.

Eversole LR, Miyasaki KT, Christensen RE.

Arch Oral Biol. 1992 Nov;37(11):963-8.

PMID:
1466643
18.

The differential effects of polymorphonuclear leukocyte secretion on human natural killer cell activity.

Lala A, Lindemann RA, Miyasaki KT.

Oral Microbiol Immunol. 1992 Apr;7(2):89-95.

PMID:
1528637
19.

The neutrophil: mechanisms of controlling periodontal bacteria.

Miyasaki KT.

J Periodontol. 1991 Dec;62(12):761-74. Review.

PMID:
1765939
20.

Sensitivity of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus to oxidative killing.

Dongari AI, Miyasaki KT.

Oral Microbiol Immunol. 1991 Dec;6(6):363-72.

PMID:
1668250
21.

Prevalence and severity of periodontal disease in patients with inflammatory bowel disease.

Flemmig TF, Shanahan F, Miyasaki KT.

J Clin Periodontol. 1991 Oct;18(9):690-7.

PMID:
1960238
22.
25.

Secretion of myeloperoxidase isoforms by human neutrophils.

Miyasaki KT, Song JP, Murthy RK.

Anal Biochem. 1991 Feb 15;193(1):38-44.

PMID:
1645935
26.

In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins.

Miyasaki KT, Bodeau AL, Ganz T, Selsted ME, Lehrer RI.

Infect Immun. 1990 Dec;58(12):3934-40.

27.

Killing of oral, gram-negative, facultative bacteria by the rabbit defensin, NP-1.

Miyasaki KT, Bodeau AL, Selsted ME, Ganz T, Lehrer RI.

Oral Microbiol Immunol. 1990 Dec;5(6):315-9.

PMID:
2098709
28.
29.

Detachment of oral bacteria from saliva-coated hydroxyapatite by human polymorphonuclear leukocytes.

Erard JC, Miyasaki KT, Wolinsky LE.

J Periodontol. 1989 Apr;60(4):211-6.

PMID:
2724035
30.

Differential modulation of adherence of oral streptococci by human neutrophil myeloperoxidase.

Miyasaki KT, de Camargo PM, Wolinsky LE.

J Dent Res. 1988 Oct;67(10):1300-6.

PMID:
2844867
31.
32.

Induction of activated lymphocyte killing by bacteria associated with periodontal disease.

Lindemann RA, Miyasaki KT, Wolinsky LE.

J Dent Res. 1988 May;67(5):846-50.

PMID:
3130415
33.
35.
36.

Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils.

Miyasaki KT, Wilson ME, Brunetti AJ, Genco RJ.

Infect Immun. 1986 Jul;53(1):154-60.

37.

Evidence for and partial characterization of three major and three minor chromatographic forms of human neutrophil myeloperoxidase.

Miyasaki KT, Wilson ME, Cohen E, Jones PC, Genco RJ.

Arch Biochem Biophys. 1986 May 1;246(2):751-64.

PMID:
3010869
38.

Failure of vancomycin prophylaxis and treatment for Actinobacillus actinomycetemcomitans endocarditis.

Eng RH, Smith SM, Goldstein EJ, Miyasaki KT, Quah SE, Buccini F.

Antimicrob Agents Chemother. 1986 Apr;29(4):699-700.

41.

Prostaglandin E2 binding and cyclic AMP production in isolated bone cells.

Dziak RM, Hurd D, Miyasaki KT, Brown M, Weinfeld N, Hausmann E.

Calcif Tissue Int. 1983;35(2):243-9.

PMID:
6303530
42.

Supplemental Content

Loading ...
Support Center